EUVIMEDEUVIMED entdecken
Crossref

Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases

Katrin Beyer, Montserrat Domingo-Sábat, José I Lao, Cristina Carrato, Isidro Ferrer, Aurelio Ariza

Neurogenetics · 2008-02 · 9 (1) · 15-23

DOI: 10.1007/s10048-007-0106-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogenetics, online erschienen am 23.10.2007. Verfasst von Katrin Beyer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Barcelona, Spain. katrinbeyer@hotmail.com. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative splicing is an important mechanism to generate a large number of mRNAs, thus increasing proteome diversity and tissue specificity. Three transcript variants of alpha-synuclein, a neuronal protein mainly involved in synapses, have been described so far. Whereas alpha-synuclein 140 is the whole and main transcript, alpha-synuclein 112 and 126 are short proteins that result from in-frame deletions of exons 3 and 5, respectively. Because the aforesaid alpha-synuclein isoforms show differential expression changes in Lewy body diseases (LBDs), in the present work, we searched for a fourth alpha-synuclein isoform and studied its expression levels in LBD brains. By using isoform-specific primers, isoform co-amplification and direct sequencing, we identified alpha-synuclein 98, which lacks exons 3 and 5. mRNA expression analyses in non-neuronal tissue revealed that alpha-synuclein 98 is a brain-specific splice variant with varying expression levels in different areas of fetal and adult brain. Additionally, we studied alpha-synuclein 98 expression levels by real-time semi-quantitative RT-PCR in the frontal cortices of LBD patients and compared them with those of Alzheimer disease (AD) patients and control subjects. Overexpression of alpha-synuclein 98 in LBD and AD brains would indicate its specific involvement in the pathogenesis of these neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAlternative SplicingAlzheimer DiseaseAmino Acid SequenceBase SequenceBrainCase-Control StudiesDNA PrimersExonsFetusFrontal LobeGene ExpressionHumansLewy Body DiseaseMolecular Sequence DataProtein IsoformsRNA, MessengerReverse Transcriptase Polymerase Chain ReactionSequence Homology, Amino Acidalpha-Synuclein

Substanzen

DNA PrimersProtein IsoformsRNA, MessengerSNCA protein, humanalpha-Synuclein

Autor:innen und Institutionen

  • Department of Pathology, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Barcelona, Spain. katrinbeyer@hotmail.com

Zitieren

APA

Beyer, K., Domingo-Sábat, M., Lao, J. I., Carrato, C., Ferrer, I., & Ariza, A. (2008). Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases. Neurogenetics, 9(1), 15-23. https://doi.org/10.1007/s10048-007-0106-0

Vancouver

Beyer K, Domingo-Sábat M, Lao JI, Carrato C, Ferrer I, Ariza A. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases. Neurogenetics. 2008;9(1):15-23. doi:10.1007/s10048-007-0106-0

BibTeX
@article{Beyer2008,
  author = {Beyer, Katrin and Domingo-Sábat, Montserrat and Lao, José I and Carrato, Cristina and Ferrer, Isidro and Ariza, Aurelio},
  title = {Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases},
  journal = {Neurogenetics},
  year = {2008},
  volume = {9},
  number = {1},
  pages = {15--23},
  doi = {10.1007/s10048-007-0106-0}
}
Kostenlos starten →